검색어: esophagitis (영어 - 덴마크어)

esophagitis
oesophagitis

reflux esophagitis
refluksøsofagitis

esophagitis, gastritis and gastroesophageal reflux
Øsofagitis, gastritis eller gastroøsofageal refluks

esophagitis, oral paresthesia, rectal haemorrhage
esofagitis, oral paræstesi, rektalblødning

esophagitis/dysphagia/ odynophagia (g3/4:
diarré (g3/4: 6,8 %); Øsofagitis/dys-

patients with gastritis, esophagitis or gastroesophageal reflux
patienter med gastritis, øsofagitis eller gastroøsofageal refluks

esophagitis/dysphagia/ odynophagia (g3/4: 12.0%);
konstipation; Øsofagitis/dysfagi/ odynofagi (g3/4: 0,6 %); gastrointestinale smerter;

constipation; esophagitis/ dysphagia/ odynophagia (g3/ 4:
konstipation; oesophagitis/ dysfagi / odynofagi (g3/ 4:

6.8%); esophagitis/ dysphagia/ odynophagia (g3/ 4:
6, 8%); esophagitis/ dysphagi/ o dynophagi (g3/ 4:

constipation esophagitis/dysphagia/ odynophagia (g3/4: 0.6%);
Øsofagitis/dysfagi/odynofagi (g3/4: 0,7 %)

constipation; esophagitis/dysphagia/ odynophagia (g3/4: 0.6%);
obstipation; Øsofagitis/dysfagi/ odynofagi (g3/4: 0,6%);

difficulty or pain when swallowing, chest pain, heartburn or acid reflux (esophagitis).
besvær med eller smerte ved synkning, brystsmerter, halsbrand eller sure opstød (betændelse i spiserøret)

esophagitis, nausea and vomiting, gastritis, dysphagia, dry mouth, flatulence, gingivitis, taste perversion
mundsår, esofagitis, kvalme og opkastning, gastritis, dysfagi, mundtørhed, flatulence, tandkødsbetændelse, smagsforandring

intravenous mepolizumab pharmacokinetics was evaluated by population pharmacokinetic analysis in a paediatric study conducted in subjects aged 2–17 years old with eosinophilic esophagitis.
farmakokinetikken af intravenøs mepolizumab blev evalueret ved en farmakokinetisk populationsanalyse i et pædiatrisk studie hos personer i alderen 2-17 år med eosinofil øsofagitis.

there are limited pharmacokinetic data available in the paediatric population (59 subjects with eosinophilic esophagitis, 19 subjects with severe asthma).
der er begrænsede farmakokinetiske data tilgængelige for den pædiatriske population (59 personer med eosinofil øsofagitis, 19 personer med svær astma).

cases reported include recall phenomenon, radiation skin injury, radiation pneumonitis, radiation esophagitis, radiation proctitis, radiation hepatitis, cystitis radiation, and radiation necrosis.
det er rapporteret tilfælde af radiation recall syndrom, stråleskader på huden, stråle pneumonitis, stråle øsofagitis, stråle proktitis, stråle hepatitis, stråle cystitis og stråle nekrose

diarrhoea (g3/4: 6.8%); esophagitis/dysphagia/odynophagi a (g3/4: 12.0%);
diarré (g3/4: 6,8 %); Øsofagitis/dys- fagi/odynofagi (g3/4: 12,0 %)